A clinical study to evaluate the efficacy of two different types of blood products in the gum enhancement around implant as well as in the acceleration of healing process in partial tooth loss patients.
Not Applicable
- Conditions
- Health Condition 1: K084- Partial loss of teeth
- Registration Number
- CTRI/2024/05/066717
- Lead Sponsor
- Dr Thota Saranya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who necessitated implant placement in mandibular posterior region
2.Patients with less than 2mm of peri implant mucosa
Exclusion Criteria
1.Patients with uncontrolled systemic diseases
2. Pregnancy or lactating women
3. Chronic smokers
4. Patients with infectious diseases (HIV, Hepatitis B or Hepatitis C)
5. Patients undergoing radiation therapy
6. Patients under bisphosphonate therapy
7.Patients under antibiotic therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Peri-implant mucosal thicknessTimepoint: Peri-implant mucosal thickness will be assessed at baseline, 30 days and 45 days
- Secondary Outcome Measures
Name Time Method 1.Width of Keratinized mucosa <br/ ><br>2.Peri-implant mucosal healing <br/ ><br>Timepoint: Width of Keratinized mucosa will be assessed at baseline, 30 days and 45 days <br/ ><br>Peri-implant mucosal healing will be assessed at 2 weeks <br/ ><br>